While concerns about long-term daily use exist primarily due to limited data rather than proven harm, these agents should ideally be used under healthcare provider guidance if needed regularly
In 2023, semaglutide was the best-selling drug in the United States with nearly $14 billion in sales.1 There are an estimated 100 million obese adults in America, and an additional 37 million who may also be eligible to use medications like GLP-1s to manage chronic conditions
To know if nutritional supplements are indeed helpful or if they are just marketing hype, read: Nutritional Supplements or a Suckers Delight
The Wegovy pill appears to produce weight loss in the same general range as injectable Wegovy
In this regard, semaglutide (RR 1.6194 [95% CI 0.8897, 2.9474
GLP-1 medications can help lower inflammation and support weight loss, both of which are important in PsA